| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ef8907f6c11525e7507a0a2408187c2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
| filingDate |
2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3f228386ee5d28690d6436e4a015255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_982dd32d1223146ba92ebed64ff520c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80624320ec5dfab7dee57c68f9ff8332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29535ffc9f7984e1464accd3ab76ed12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8867f08f5fa9de24c7dce20266cc7e6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e931f7e2c58dc325b5c33b1b5589928
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e32513c678d6827308281486d7917268 |
| publicationDate |
2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106581015-A |
| titleOfInvention |
A composition and its application in the preparation of anti-platelet aggregation and/or anti-platelet adhesion drugs |
| abstract |
An embodiment of the present invention provides a compound composition comprising (Z)-ligustilide, licochalcone A and pentagalloyl glucose. Further, the embodiment of the invention provides a pharmaceutical composition, comprising the compound composition and a pharmaceutically acceptable carrier or excipient. The compound composition and pharmaceutical composition provided by the present invention realize anti-platelet aggregation and/or anti-platelet adhesion by inhibiting the activity of cyclooxygenase, and thus can be used to prepare anti-platelet aggregation and/or anti-platelet adhesion drugs. |
| priorityDate |
2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |